Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: 165.6B DKK
Have any thoughts about
Novozymes A/S?
Write Note

Balance Sheet

Balance Sheet Decomposition
Novozymes A/S

Current Assets 9.5B
Cash & Short-Term Investments 1.2B
Receivables 4.3B
Other Current Assets 4B
Non-Current Assets 18.9B
Long-Term Investments 267m
PP&E 12.3B
Intangibles 4.5B
Other Non-Current Assets 1.8B
Current Liabilities 7.3B
Accounts Payable 1.6B
Other Current Liabilities 5.6B
Non-Current Liabilities 7.2B
Long-Term Debt 4.6B
Other Non-Current Liabilities 2.6B

Balance Sheet
Novozymes A/S

Rotate your device to view
Balance Sheet
Currency: DKK
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
839
812
632
723
711
1 181
963
1 041
1 116
Cash Equivalents
839
812
632
723
711
1 181
963
1 041
1 116
Short-Term Investments
20
4
16
14
15
119
75
80
40
Total Receivables
3 008
3 089
2 903
3 278
3 649
3 227
3 793
4 317
4 347
Accounts Receivables
2 515
2 613
2 509
2 885
3 107
2 555
2 988
3 605
3 772
Other Receivables
493
476
394
393
542
672
805
712
575
Inventory
2 281
2 488
2 586
2 820
2 613
2 361
2 992
3 803
3 627
Other Current Assets
0
0
0
0
62
23
0
0
332
Total Current Assets
6 148
6 393
6 137
6 835
7 050
6 911
7 823
9 241
9 462
PP&E Net
8 162
8 641
8 926
9 698
10 212
9 612
10 185
12 074
12 325
PP&E Gross
8 162
8 641
8 926
9 698
10 212
9 612
10 185
12 074
12 325
Accumulated Depreciation
8 832
9 469
9 624
10 335
11 052
11 437
12 896
13 776
13 894
Intangible Assets
1 536
1 578
1 324
1 044
961
1 456
3 004
2 691
2 557
Goodwill
1 140
1 159
1 108
1 086
965
1 098
2 020
2 007
1 975
Note Receivable
116
57
35
34
29
40
39
32
43
Long-Term Investments
230
224
88
62
59
54
59
315
267
Other Long-Term Assets
459
607
755
938
1 161
1 339
1 637
1 623
1 762
Other Assets
1 140
1 159
1 108
1 086
965
1 098
2 020
2 007
1 975
Total Assets
17 791
N/A
18 659
+5%
18 373
-2%
19 697
+7%
20 437
+4%
20 510
+0%
24 767
+21%
27 983
+13%
28 391
+1%
Liabilities
Accounts Payable
1 189
1 194
1 341
1 418
1 117
1 100
1 490
1 869
1 616
Accrued Liabilities
753
712
671
723
748
583
685
693
820
Short-Term Debt
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
74
89
971
1 789
1 543
1 242
2 151
2 941
3 172
Other Current Liabilities
1 284
1 567
1 594
1 595
1 327
1 236
1 347
1 460
1 654
Total Current Liabilities
3 300
3 562
4 577
5 525
4 735
4 161
5 673
6 963
7 262
Long-Term Debt
1 202
1 714
1 303
1 469
3 159
3 630
4 037
3 907
4 561
Deferred Income Tax
715
854
721
892
879
1 204
1 337
1 653
1 965
Minority Interest
13
13
13
13
12
11
379
391
373
Other Liabilities
981
784
505
373
184
271
1 514
1 232
252
Total Liabilities
6 211
N/A
6 927
+12%
7 119
+3%
8 272
+16%
8 969
+8%
9 277
+3%
12 940
+39%
14 146
+9%
14 413
+2%
Equity
Common Stock
626
620
610
594
582
570
564
562
562
Retained Earnings
10 396
10 483
10 861
10 943
10 810
11 263
11 303
13 062
13 755
Other Equity
558
629
217
112
76
600
40
213
339
Total Equity
11 580
N/A
11 732
+1%
11 254
-4%
11 425
+2%
11 468
+0%
11 233
-2%
11 827
+5%
13 837
+17%
13 978
+1%
Total Liabilities & Equity
17 791
N/A
18 659
+5%
18 373
-2%
19 697
+7%
20 437
+4%
20 510
+0%
24 767
+21%
27 983
+13%
28 391
+1%
Shares Outstanding
Common Shares Outstanding
303
298
293
288
281
279
277
277
277

See Also

Discover More